Research programme: antimicrobial therapeutics - Locus Biosciences
Alternative Names: LBx PA01Latest Information Update: 28 Feb 2022
At a glance
- Originator Locus Biosciences
- Class Antibacterials; RNA
- Mechanism of Action Bacterial DNA inhibitors; Gene transference
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Bacterial infections; Pseudomonal infections
Most Recent Events
- 28 Feb 2022 No recent reports of development identified for research development in Pseudomonal-infections in USA
- 28 Dec 2021 No recent reports of development identified for research development in Bacterial-infections in USA
- 12 Jan 2018 Locus Biosciences and IDbyDNA agree to co-develop diagnostic test for Pseudomonal infections